Vifor Fresenius Medical Care Renal Pharma is a rapidly-growing international company that focuses on nephrology. We combine the strengths of our two shareholders: Vifor Pharma, a pharmaceutical company specialising in the treatment of iron deficiency, and Fresenius Medical Care, one of the world’s leading providers of expert patient care and dialysis services.
www.viforpharma.com
www.shptchallenges.com
Vifor Fresenius Medical Care Renal Pharma supports the Nephro Update Europe 2022 as Partner.
Astellas supports the Nephro Update Europe 2022 as Partner.
contribute to the health and well-being of people around
the world by creating new value through the pursuit of
advances in life sciences and technologies.
Kyowa Kirin supports the Nephro Update Europe 2022 as Partner.
We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions.
Medtronic supports the Nephro Update Europe 2022 as Partner.
Boehringer Ingelheim Lilly Alliance supports the Nephro Update Europe 2022 as Partner.
Hansa’s research and development program is also advancing the Company’s enzyme technology to develop the next generation of IgG-cleaving enzymes with potentially lower immunogenicity, suitable for repeat dosing in relapsing autoimmune diseases and oncology. Hansa Biopharma is based in Lund, Sweden and also has operations in other European countries and in the U.S.
Hansa Biopharma supports the Nephro Update Europe 2022 as Partner.
AstraZeneca supports the Nephro Update Europe 2022 as Partner.
Bayer supports the Nephro Update Europe 2022 as Partner.
Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients.
We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people, and affordable access to our medicines in some of the world’s poorest countries.
Sanofi supports the Nephro Update Europe 2022 as Partner.
